CDC-9 Inactivated Rotavirus Vaccine (IRV) Intramuscular (IM) Phase 1 Clinical Trial in Healthy Adults

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
This is a study of CDC-9 inactivated rotavirus vaccine (IRV) for intramuscular administration (IM) in healthy adults aged 18 to 45 years at two dose levels in a 3-dose series. The purpose is to determine if it is safe and if the recipient\'s immune system responds to the vaccine.
Epistemonikos ID: bf0de86e05a5fccbe99f4e208996fcf43c765db1
First added on: Apr 17, 2025